OLFM4, olfactomedin 4, 10562

N. diseases: 89; N. variants: 3
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.040 AlteredExpression group BEFREE Overall, suppression of OLFM4 expression may be a promising strategy in the development of novel cancer therapeutic drugs. 26398045 2015
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.040 AlteredExpression group BEFREE OLFM4 expression level in NSCLC lesions was strongly correlated with pathologic grade (P = .017), lymph node metastasis (P = .012), peritumor intravascular cancer emboli (P = .03), and smoking status (P < .001). 25771901 2015
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.040 Biomarker group BEFREE In addition, OLFM4 is associated with cancer adhesion and metastasis. 21067260 2011
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.040 AlteredExpression group BEFREE Measurement of Reg IV and GW112 levels in sera indicated a sensitivity of 57% for detection of cancer. 19261089 2009